BlackRock »

Generate Biomedicines Ord shares owned by BlackRock

Quarter-by-quarter ownership of Generate Biomedicines Ord (GENB) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Generate Biomedicines Ord

Tip: Access up to 7 years of quarterly data

All positions including Generate Biomedicines Ord held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Generate Biomedicines Ord by BlackRock

Quarter filed Position value Share count Share price at filing
2026-06-30 $28M 1.7M 16.87

More positions owned by BlackRock

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for BlackRock

Top funds holding Generate Biomedicines Ord

Flagship Ventures Management
FMR
Capital World Investors
Braidwell
T. Rowe Price Associates
Norges Bank Investment Management
Arch Venture Corp
HarbourVest Partners
BlackRock
Baker Bros. Advisors
Jpmorgan Chase & Co
Deep Track Capital
ARK Investment Management
Vanguard Capital Management
Harvard Management Company

View all funds holding Generate Biomedicines Ord